Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -15.44 is 5224% below its 5-year average of -0.29, around the middle of its 5-year range (-30.54–19.24).
34.62% above its 12-month average of -23.62.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-28): -1.36.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:47:43.455Z. Historical observations retain their original dates. Historical series through 2024-02-29.
EARNINGS PER SHARE (EPS)
-15.44
EARNINGS PER SHARE (EPS) AVG TTM
-23.62
EARNINGS PER SHARE (EPS) AVG 3Y
-9.43
EARNINGS PER SHARE (EPS) AVG 5Y
-0.29
EARNINGS PER SHARE (EPS) AVG 10Y
0.09
EARNINGS PER SHARE (EPS) AVG 15Y
0.23
EARNINGS PER SHARE (EPS) AVG 20Y
0.31
CURRENT VS TTM AVG
+34.62%
CURRENT VS 3Y AVG
-63.73%
CURRENT VS 5Y AVG
-5224.14%
CURRENT VS 10Y AVG
-18168.09%
CURRENT VS 15Y AVG
-6813.04%
CURRENT VS 20Y AVG
-5011.33%
QuidelOrtho Corporation
Market Cap
$842.16M
Earnings Per Share (EPS)
-15.44
TTM Avg
-23.62
3Y Avg
-9.43
5Y Avg
-0.29
Market Cap
$840.68M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.25
3Y Avg
-1.25
5Y Avg
-1.25
Market Cap
$838.83M
Earnings Per Share (EPS)
-1.68
TTM Avg
-1.54
3Y Avg
-1.41
5Y Avg
-1.41
Market Cap
$843.28M
Earnings Per Share (EPS)
-0.43
TTM Avg
-1.48
3Y Avg
-1.39
5Y Avg
-1.04
Market Cap
$837.55M
Earnings Per Share (EPS)
-3.80
TTM Avg
-6.69
3Y Avg
-9.43
5Y Avg
-9.43
Market Cap
$835.44M
Earnings Per Share (EPS)
-2.18
TTM Avg
-0.78
3Y Avg
-1.63
5Y Avg
-1.49
Market Cap
$857.96M
Earnings Per Share (EPS)
N/A
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$856.52M
Earnings Per Share (EPS)
-0.34
TTM Avg
-0.59
3Y Avg
-1.03
5Y Avg
-1.22
Market Cap
$863.17M
Earnings Per Share (EPS)
16.32
TTM Avg
10.69
3Y Avg
4.14
5Y Avg
2.27
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| QuidelOrtho Corporation (QDEL) | $842.16M | -15.44 | -23.62 | -9.43 | -0.29 |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $840.68M | N/A | -1.25 | -1.25 | -1.25 |
| Beta Bionics, Inc. (BBNX)vs › | $838.83M | -1.68 | -1.54 | -1.41 | -1.41 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $843.28M | -0.43 | -1.48 | -1.39 | -1.04 |
| Alumis Inc. (ALMS)vs › | $837.55M | -3.80 | -6.69 | -9.43 | -9.43 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $835.44M | -2.18 | -0.78 | -1.63 | -1.49 |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | N/A | 0.00 | 0.00 | 0.00 |
| SI-BONE, Inc. (SIBN)vs › | $856.52M | -0.34 | -0.59 | -1.03 | -1.22 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.17M | 16.32 | 10.69 | 4.14 | 2.27 |
| Ardelyx, Inc. (ARDX)vs › | $813.96M | -0.23 | -0.22 | -0.29 | -0.62 |
Trailing EPS (TTM)
$-15.44
Forward EPS (Est.)
$0.77
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-28 | -16.69 |
| 2024-12-29 | -30.54 |
| 2023-12-31 | -0.15 |
| 2023-01-01 | 9.66 |
| 2021-12-31 | 16.74 |
| 2020-12-31 | 19.24 |
| 2019-12-31 | 1.78 |
| 2018-12-31 | 1.74 |
| 2017-12-31 | -0.24 |
| 2016-12-31 | -0.42 |
| 2015-12-31 | -0.18 |
| 2014-12-31 | -0.21 |
| 2013-12-31 | 0.22 |
| 2012-12-31 | 0.15 |
| 2011-12-31 | 0.23 |
| 2010-12-31 | -0.39 |
| 2009-12-31 | 1.10 |
| 2008-12-31 | 0.59 |
| 2007-12-31 | 0.43 |
| 2006-12-31 | 0.66 |
| 2005-12-31 | -0.28 |
| 2004-12-31 | -0.20 |
| 2003-12-31 | 0.67 |
| 2002-12-31 | 0.04 |
| 2001-12-31 | 0.01 |
| 2000-12-31 | -0.23 |
| 1999-03-31 | 0.32 |
| 1998-03-31 | 0.05 |
| 1997-03-31 | 0.16 |
| 1996-03-31 | 0.03 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T18:47:43.455Z. Historical observations retain their original dates. Historical series through 2019-12-31.
